Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOCINONIDE Cause Application site pain? 24 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Application site pain have been filed in association with FLUOCINONIDE (Fluocinonide). This represents 2.3% of all adverse event reports for FLUOCINONIDE.

24
Reports of Application site pain with FLUOCINONIDE
2.3%
of all FLUOCINONIDE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Application site pain From FLUOCINONIDE?

Of the 24 reports, 1 (4.2%) resulted in death, 1 (4.2%) required hospitalization, and 1 (4.2%) were considered life-threatening.

Is Application site pain Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOCINONIDE. However, 24 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOCINONIDE Cause?

Drug ineffective (458) Psoriasis (238) Pruritus (119) Product use in unapproved indication (102) Treatment failure (97) Therapeutic product effect incomplete (96) Skin exfoliation (71) Rash (65) Erythema (64) Off label use (47)

What Other Drugs Cause Application site pain?

MINOXIDIL (1,863) CRISABOROLE (1,414) PEGFILGRASTIM (1,258) SUMATRIPTAN (1,217) INGENOL MEBUTATE (1,012) NICOTINE (1,005) BUPRENORPHINE (712) ESTRADIOL (551) TESTOSTERONE (511) DICLOFENAC (424)

Which FLUOCINONIDE Alternatives Have Lower Application site pain Risk?

FLUOCINONIDE vs FLUORESCEIN FLUOCINONIDE vs FLUOROMETHOLONE FLUOCINONIDE vs FLUOROURACIL FLUOCINONIDE vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN FLUOCINONIDE vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN\OXALIPLATIN

Related Pages

FLUOCINONIDE Full Profile All Application site pain Reports All Drugs Causing Application site pain FLUOCINONIDE Demographics